내시경역행담췌관조영술(ERCP) 시장 규모, 점유율, 성장 분석 : 제품 유형별, 시술별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Endoscopic Retrograde Cholangiopancreatography Market size was valued at USD 1.65 Billion in 2024 and is poised to grow from USD 1.81 Billion in 2025 to USD 3.82 Billion by 2033, growing at a CAGR of 9.8% during the forecast period (2026-2033).

The growing preference for minimally invasive surgical techniques is driving an increased demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures, leading to a burgeoning market. This rise in ERCP interventions is largely attributed to the benefits associated with these approaches, including shorter recovery times and a lower incidence of complications relative to traditional surgeries. Moreover, the increasing prevalence of conditions like liver cancer underscores the urgent requirement for advanced diagnostic and therapeutic options. As healthcare continues to innovate, the ERCP market is positioned for substantial growth, reflecting a broader trend towards more effective and less invasive medical practices that prioritize patient outcomes and enhance overall healthcare efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Endoscopic Retrograde Cholangiopancreatography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Endoscopic Retrograde Cholangiopancreatography Market Segments Analysis

Global Endoscopic Retrograde Cholangiopancreatography Market is segmented by Product Type, Procedure, End Users and region. Based on Product Type, the market is segmented into Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices and Others. Based on Procedure, the market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dialtation, Pancreatic Sphincterotomy, Pancreatic Duct Stenting and Pancreatic Duct Dilatation. Based on End Users, the market is segmented into Hospitals, Ambulatory Surgery Centers & Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Endoscopic Retrograde Cholangiopancreatography Market

The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) market is driven by the increasing demand for advanced diagnostic and therapeutic solutions targeting disorders of the pancreas, liver, gallbladder, and bile ducts. This innovative technique combines endoscopic and fluoroscopic methods, allowing healthcare professionals to visualize and treat conditions affecting the pancreatobiliary system effectively. By employing a flexible, illuminated endoscope alongside X-ray imaging, ERCP provides a detailed assessment of these critical organs, enhancing treatment outcomes. The ability to diagnose and manage complex maladies with a minimally invasive approach is attracting more healthcare facilities to adopt this technology, thereby fueling market growth and expansion.

Restraints in the Global Endoscopic Retrograde Cholangiopancreatography Market

The growth of the global endoscopic retrograde cholangiopancreatography market faces significant challenges due to strict regulatory guidelines enforced by governing bodies in various countries. These regulations create obstacles for the introduction of innovative technologies, as compliance demands extensive testing and strict adherence to safety and efficacy standards. This results in a complicated and lengthy approval process for new medical devices. Despite these regulatory constraints, there are positive influences on the market, including an increase in disposable income in developing countries, which has become a key driver of market growth, fostering greater accessibility and improving overall healthcare outcomes.

Market Trends of the Global Endoscopic Retrograde Cholangiopancreatography Market

The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) market is poised for substantial growth driven by strategic initiatives from leading players. Key industry participants are focusing on innovative product launches, partnerships, mergers, and acquisitions to enhance their offerings and improve patient outcomes. Collaborative ventures, such as those between technology firms specializing in hemostasis solutions and established endoscopic equipment manufacturers, underscore a commitment to advancing treatment methodologies. This trend reflects a broader movement within the healthcare sector towards integrating cutting-edge technologies and fostering collaboration, ultimately aiming to optimize procedural efficiency and enhance the safety of gastrointestinal interventions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Endoscopic Retrograde Cholangiopancreatography Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Endoscopes
• Endotherapy Devices
  • Sphincterotomes
  • Lithotripter
  • Stents
  • Cannulas
  • Forceps
  • Snares
  • Catheters
  • Guiding Wires
  • Balloons
  • Baskets
• Visualization Systems
• Energy Devices
• Others

Global Endoscopic Retrograde Cholangiopancreatography Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Biliary Sphincterotomy
• Biliary Stenting
• Biliary Dialtation
• Pancreatic Sphincterotomy
• Pancreatic Duct Stenting
• Pancreatic Duct Dilatation

Global Endoscopic Retrograde Cholangiopancreatography Market Size by End Users & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgery Centers & Clinics
• Others

Global Endoscopic Retrograde Cholangiopancreatography Market Size & CAGR (2026-2033)

• North America (Product Type, Procedure, End Users)
  • US
  • Canada
• Europe (Product Type, Procedure, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Procedure, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Procedure, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Procedure, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CONMED Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HOYA Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STERRIS PLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TeleMed Systems Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DCC Healthcare (Medi-Globe GmbH) (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huger Medical Instrument Co. Ltd (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SonoScape Medical Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KARL STORZ SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ambu A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PENTAX Medical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sony Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations